Two Sigma Advisers’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History
Bought
Maintained
Sold
Other funds holding LKFT
Two Sigma Advisers's LKFT Position: Q1 2026 in Review
Two Sigma Advisers sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2026, closing a stake of 11,300 shares — an estimated $370K sold.
Two Sigma Advisers first reported a position in LKFT in Q3 2021 and held it in 7 quarters. The position peaked at $1.09M in Q1 2025. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.
- Two Sigma Advisers reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q1 2026 after selling out during the quarter.
- Two Sigma Advisers sold 11,300 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2026, an estimated $370K.
- Two Sigma Advisers first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2021 and held it in 7 quarters.
- Two Sigma Advisers's Lakefront Biotherapeutics American Depositary Shares position peaked at $1.09M in Q1 2025.
- 90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.
Based on Two Sigma Advisers's 13F filing for Q1 2026.